Nanomedicine Market
Nanomedicine Market - Global Industry Assessment & Forecast
#
Pages:
149
Base Year:
2022
Jun - 2022
Format:
Report Code:
VMR-1632
Segments Covered
By
Modality Diagnostics, Treatment
-
By
Application Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, Others
-
By
Indication Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Neurology, Urology, Ophthalmology, Immunology, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 188.05 Billion |
 Revenue 2030:
|
USD 366.53 Billion |
 Revenue CAGR
(2023 - 2030): |
8.70% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Nanomedicine Market Segment Analysis
- Nanomedicine Modality Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostics
- Treatment
- Nanomedicine Application Outlook (Revenue, USD Million, 2018 - 2030)
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Nanomedicine Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Nanomedicine Market, by Modality
- Diagnostics
- Treatment
-
North America Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
-
North America Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- U.S.
- U.S. Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- U.S. Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- U.S. Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- U.S. Nanomedicine Market, by Modality
- Canada
- Canada Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Canada Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Canada Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Canada Nanomedicine Market, by Modality
-
Mexico
- Mexico Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Mexico Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Mexico Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Mexico Nanomedicine Market, by Modality
-
North America Nanomedicine Market, by Modality
- Europe
-
Europe Nanomedicine Market, by Modality
- Diagnostics
- Treatment
-
Europe Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
-
Europe Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- U. K.
- U.K. Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- U.K. Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- U.K. Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- U.K. Nanomedicine Market, by Modality
- France
- France Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- France Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- France Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- France Nanomedicine Market, by Modality
-
Germany
- Germany Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Germany Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Germany Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Germany Nanomedicine Market, by Modality
-
Italy
- Italy Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Italy Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Italy Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Italy Nanomedicine Market, by Modality
-
Spain
- Spain Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Spain Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Spain Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Spain Nanomedicine Market, by Modality
-
Rest of Europe
- Rest of Europe Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Rest of Europe Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Rest of Europe Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Rest of Europe Nanomedicine Market, by Modality
-
Europe Nanomedicine Market, by Modality
- Asia Pacific
-
Asia Pacific Nanomedicine Market, by Modality
- Diagnostics
- Treatment
-
Asia Pacific Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
-
Asia Pacific Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- China
- China Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- China Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- China Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- China Nanomedicine Market, by Modality
- Japan
- Japan Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Japan Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Japan Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Japan Nanomedicine Market, by Modality
-
Germany
- Germany Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Germany Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Germany Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Germany Nanomedicine Market, by Modality
-
India
- India Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- India Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- India Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- India Nanomedicine Market, by Modality
-
South Korea
- South Korea Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- South Korea Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- South Korea Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- South Korea Nanomedicine Market, by Modality
-
South East Asia
- South East Asia Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- South East Asia Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- South East Asia Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- South East Asia Nanomedicine Market, by Modality
-
Rest of Asia Pacific
- Rest of Asia Pacific Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Rest of Asia Pacific Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Rest of Asia Pacific Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Rest of Asia Pacific Nanomedicine Market, by Modality
-
Asia Pacific Nanomedicine Market, by Modality
- Latin America
-
Latin America Nanomedicine Market, by Modality
- Diagnostics
- Treatment
-
Latin America Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
-
Latin America Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Brazil
- Brazil Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Brazil Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Brazil Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Brazil Nanomedicine Market, by Modality
- Argentina
- Argentina Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Argentina Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Argentina Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Argentina Nanomedicine Market, by Modality
-
Rest of Latin America
- Rest of Latin America Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Rest of Latin America Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Rest of Latin America Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Rest of Latin America Nanomedicine Market, by Modality
-
Latin America Nanomedicine Market, by Modality
- Middle East & Africa
-
Middle East & Africa Nanomedicine Market, by Modality
- Diagnostics
- Treatment
-
Middle East & Africa Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
-
Middle East & Africa Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- GCC Countries
- GCC Countries Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- GCC Countries Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- GCC Countries Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- GCC Countries Nanomedicine Market, by Modality
- South Africa
- South Africa Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- South Africa Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- South Africa Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- South Africa Nanomedicine Market, by Modality
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Nanomedicine Market, by Modality
- Diagnostics
- Treatment
- Rest of Middle East & Africa Nanomedicine Market, by Application
- Drug Delivery
- Diagnostic Imaging
- Vaccines
- Regenerative Medicine
- Implants
- Others
- Rest of Middle East & Africa Nanomedicine Market, by Indication
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Neurology
- Urology
- Ophthalmology
- Immunology
- Others
- Rest of Middle East & Africa Nanomedicine Market, by Modality
-
Middle East & Africa Nanomedicine Market, by Modality
- North America
Vantage Market
Research | 06-Jun-2022
FAQ
Frequently Asked Question
What is the global demand for Nanomedicine in terms of revenue?
-
The global Nanomedicine valued at USD 188.05 Billion in 2022 and is expected to reach USD 366.53 Billion in 2030 growing at a CAGR of 8.70%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories, DiaSorin S.P.A., General Electric Company, Invitae Corporation, Johnson & Johnson, Leadient BioSciences Inc., Mallinckrodt PLC, Merck & Co. Inc. Pfizer Inc., Teva Pharmaceuticals Ltd..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.70% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Nanomedicine include
- Rising level of government participation in R&D funding
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Nanomedicine in 2022.
